Literature DB >> 29378905

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia.

Adrian Frick1, Vineeta Khare1, Gregor Paul1, Michaela Lang1, Franziska Ferk2, Siegfried Knasmüller2, Andrea Beer3, Georg Oberhuber4, Christoph Gasche5.   

Abstract

Patients with inflammatory bowel disease (IBD) have a higher risk of developing colitis-associated-cancer (CAC); however, the underlying processes of disease progression are not completely understood. Here, the molecular processes of inflammation-driven colon carcinogenesis were investigated using IL10-deficient mice (IL10 KO). IL10 KO mice were euthanized after development of colitis and dysplasia. IHC was performed for markers of colitis-induced DNA damage (CIDD): oxidative DNA lesions (8-oxoG), double-strand breaks (DSB; γH2AX). and DSB repair. MSI, LOH (Trp53, Apc), and global methylation (CIMP) were assessed on microdissected tissue. Comet assay for DNA damage, immunofluorescence, and immunoblotting were performed on intestinal organoids from wild-type (WT) and IL10 KO mice. Sequential biopsies and surgical specimens from IBD and CAC patients were used for IHC analysis. Severity of inflammation correlated with number of dysplasia. 8-oxoG and γH2AX-positive cells were significantly increased in inflamed and dysplastic areas along with activation of DSB repair. The amount of positively stained cells strongly correlated with degree of inflammation (8-oxoG: R = 0.923; γH2AX: R = 0.858). Neither CIMP, MSI nor LOH was observed. Enhanced DSBs in IL10 KO organoids were confirmed by comet assay and increased expression of γH2AX. Human clinical specimens exhibited significantly higher γH2AX and 8-oxoG in IBD, dysplasia, and CAC compared with normal mucosa. These data indicate that inflammation-driven colon carcinogenesis in IL10 KO mice and IBD patients is associated with oxidative DNA damage and overt presence of DSB. Mol Cancer Res; 16(4); 634-42. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29378905     DOI: 10.1158/1541-7786.MCR-17-0451

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  16 in total

1.  Nitro aspirin (NCX4040) induces apoptosis in PC3 metastatic prostate cancer cells via hydrogen peroxide (H2O2)-mediated oxidative stress.

Authors:  Somaiah Chinnapaka; Guoxing Zheng; Aoshuang Chen; Gnanasekar Munirathinam
Journal:  Free Radic Biol Med       Date:  2019-08-22       Impact factor: 7.376

Review 2.  Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.

Authors:  Shailja C Shah; Steven H Itzkowitz
Journal:  Gastroenterology       Date:  2021-10-29       Impact factor: 22.682

3.  Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.

Authors:  Daniel Roca-Lema; Macarena Quiroga; Vineeta Khare; Andrea Díaz-Díaz; Aida Barreiro-Alonso; Andrea Rodríguez-Alonso; Ángel Concha; Gabriela Romay; M Esperanza Cerdán; Christoph Gasche; Angélica Figueroa
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.

Authors:  Vineeta Khare; Anita Krnjic; Adrian Frick; Christina Gmainer; Mario Asboth; Kristine Jimenez; Michaela Lang; Maximilian Baumgartner; Rayko Evstatiev; Christoph Gasche
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

5.  Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome.

Authors:  Michaela Lang; Maximilian Baumgartner; Aleksandra Rożalska; Adrian Frick; Alessandra Riva; Michael Jarek; David Berry; Christoph Gasche
Journal:  Int J Cancer       Date:  2020-05-18       Impact factor: 7.396

Review 6.  A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer.

Authors:  Shuangfeng Chen; Yuebo Li; Lili Qian; Sisi Deng; Luwen Liu; Weihua Xiao; Ying Zhou
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

7.  PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.

Authors:  Naoya Ozawa; Takehiko Yokobori; Katsuya Osone; Chika Katayama; Kunihiko Suga; Chika Komine; Yuta Shibasaki; Takuya Shiraishi; Takuhisa Okada; Ryuji Kato; Hiroomi Ogawa; Akihiko Sano; Makoto Sakai; Makoto Sohda; Hitoshi Ojima; Tatsuya Miyazaki; Yoko Motegi; Munenori Ide; Takashi Yao; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

8.  Photoprotective Properties of Isothiocyanate and Nitrile Glucosinolate Derivatives From Meadowfoam (Limnanthes alba) Against UVB Irradiation in Human Skin Equivalent.

Authors:  Evan L Carpenter; Mai N Le; Cristobal L Miranda; Ralph L Reed; Jan F Stevens; Arup K Indra; Gitali Ganguli-Indra
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

9.  Paradoxical interaction between cancer and long-term postsepsis disorder: impairment of de novo carcinogenesis versus favoring the growth of established tumors.

Authors:  Caio Abner Leite; Jose Mauricio Mota; Kalil Alves de Lima; Carlos Wagner Wanderley; Leticia Almeida Nascimento; Marcela Davoli Ferreira; Camila Meirelles Souza Silva; David Fernando Colon; Juliana Yumi Sakita; Vinicius Kannen; Paula Ramos Viacava; Maria Dirlei Begnami; Roberto Cesar Pereira Lima-Junior; Vladmir Claudio Cordeiro de Lima; Jose Carlos Alves-Filho; Fernando Queiroz Cunha; Ronaldo Albuquerque Ribeiro
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

10.  Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer.

Authors:  Thergiory Irrazabal; Bhupesh K Thakur; Mingsong Kang; Yann Malaise; Catherine Streutker; Erin O Y Wong; Julia Copeland; Robert Gryfe; David S Guttman; William W Navarre; Alberto Martin
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.